Skip to content

Synojoynt

by Mesoblast

PMA P170016

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P170016↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP170016 Date8 May 2018ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Acid, hyaluronic, intraarticular
PMA Number
FDA Product Code
MOZ
Device Class
Class III
Advisory Committee
Orthopedic
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Synojoint Acid, Hyaluronic, Intraarticular is a Class III medical device classified as an intraarticular acid, hyaluronic preparation. It is designed to provide intraarticular administration of hyaluronic acid for therapeutic purposes in joint conditions, specifically targeting pain associated with osteoarthritis of the knee in patients unresponsive to conservative treatments and simple analgesics.

This device is administered via intraarticular injection into the knee joint under sterile conditions. It is supplied as a single-use product and is regulated under an FDA Premarket Approval (PMA) with PMA number P170016. The product is intended for use in clinical settings by healthcare professionals and is not reusable. No specific MRI safety information is provided in the available data.